Related Experiment Videos
Molecular mimicry in multiple sclerosis
Hartmut Wekerle1, Reinhard Hohlfeld
1Department of Neuroimmunology, Max-Planck Institute for Neurobiology, Martinsried, Germany.
The New England Journal of Medicine
|July 11, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.
Journal of neurology·2026
Same author
Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial.
Multiple sclerosis and related disorders·2025
Same author
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study.
Proceedings of the National Academy of Sciences of the United States of America·2025
Same author
Perceptual rivalry in neuroscience, magic and philosophy.
Brain : a journal of neurology·2025
Same author
Fragments of the brain's myelin proteins train T cells to ward off autoimmune attacks.
Nature·2024
Same author
Twin study identifies early immunological and metabolic dysregulation of CD8<sup>+</sup> T cells in multiple sclerosis.
Science immunology·2024
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
The New England journal of medicine·2026
Same journal
Hypertension Control in Low-Income Patients. Reply.
The New England journal of medicine·2026